Automated Scar Segmentation from CMR-LGE Images Using a Deep Learning Approach

Aim. The presence of myocardial scar is a strong predictor of ventricular remodeling, cardiac dysfunction and mortality. Our aim was to assess quantitatively the presence of scar tissue from cardiac-magnetic-resonance (CMR) with late-Gadolinium-enhancement (LGE) images using a deep-learning (DL) approach. Methods. Scar segmentation was performed automatically with a DL approach based on ENet, a deep fully-convolutional neural network (FCNN). We investigated three different ENet configurations. The first configuration (C1) exploited ENet to retrieve directly scar segmentation from the CMR-LGE images. The second (C2) and third (C3) configurations performed scar segmentation in the myocardial region, which was previously obtained in a manual or automatic way with a state-of-the-art DL method, respectively. Results. When tested on 250 CMR-LGE images from 30 patients, the best-performing configuration (C2) achieved 97% median accuracy (inter-quartile (IQR) range = 4%) and 71% median Dice similarity coefficient (IQR = 32%). Conclusions. DL approaches using ENet are promising in automatically segmenting scars in CMR-LGE images, achieving higher performance when limiting the search area to the manually-defined myocardial region

A Novel Approach Based on Spatio-temporal Features and Random Forest for Scar Detection Using Cine Cardiac Magnetic Resonance Images

Aim. To identify the presence of scar tissue in the left ventricle from Gadolinium (Gd)-free magnetic resonance cine sequences using a learning-based approach relying on spatio-temporal features. Methods. The spatial and temporal features were extracted using local binary patterns from (i) cine end-diastolic frame and (ii) two parametric images of amplitude and phase wall motion, respectively, and classified with Random Forest. Results. When tested on 328 cine sequences from 40 patients, a recall of 70% was achieved, improving significantly the classification resulting from spatial and temporal features processed separately. Conclusions. The proposed approach showed promising results, paving the way for scar identification from Gd-free images

Impact and therapy of osteoarthritis: the Arthritis Care OA Nation 2012 survey

Osteoarthritis (OA) is the fastest growing cause of disability worldwide. The aim of this study was to understand the impact of OA on individuals and to explore current treatment strategies. An online UK-wide survey of people with self-reported OA was conducted, composed of 52 questions exploring the impact of OA, diagnosis and treatment, the role of health professionals and self-management. Four thousand forty-three people were invited with 2,001 respondents (49 % response, 56 % women; mean age 65 years). Fifty-two percent reported that OA had a large impact on their lives. Fifteen percent of respondents had taken early retirement on average 7.8 years earlier than planned. In consultations with general practitioners, only half reported a discussion on pain; fewer reported discussing their fears (21 %) or management goals (15 %). Nearly half (48 %) reported not seeking medical help until pain was frequently unbearable. Oral analgesics (62 %), topical therapies (47 %), physiotherapy (38 %) and steroid injections (28 %) were commonly used. The majority (71 %) reported varying degrees of persistent pain despite taking all prescribed medication. Although 64 % knew that increasing exercise was important, only 36 % acted on this knowledge; 87 % who increased exercise found it beneficial. Over half had future concerns related to mobility (60 %), maintaining independence (52 %) and coping with everyday activities (51 %). OA had significant individual economic impact especially on employment. Current treatment strategies still leave most people in pain with significant fears for the future. There is considerable opportunity to improve the holistic nature of OA consultations especially in provision of information and promotion of self-management strategies

Ezetimibe added to statin therapy after acute coronary syndromes

BACKGROUND: Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known. METHODS: We conducted a double-blind, randomized trial involving 18,144 patients who had been hospitalized for an acute coronary syndrome within the preceding 10 days and had LDL cholesterol levels of 50 to 100 mg per deciliter (1.3 to 2.6 mmol per liter) if they were receiving lipid-lowering therapy or 50 to 125 mg per deciliter (1.3 to 3.2 mmol per liter) if they were not receiving lipid-lowering therapy. The combination of simvastatin (40 mg) and ezetimibe (10 mg) (simvastatin-ezetimibe) was compared with simvastatin (40 mg) and placebo (simvastatin monotherapy). The primary end point was a composite of cardiovascular death, nonfatal myocardial infarction, unstable angina requiring rehospitalization, coronary revascularization ( 6530 days after randomization), or nonfatal stroke. The median follow-up was 6 years. RESULTS: The median time-weighted average LDL cholesterol level during the study was 53.7 mg per deciliter (1.4 mmol per liter) in the simvastatin-ezetimibe group, as compared with 69.5 mg per deciliter (1.8 mmol per liter) in the simvastatin-monotherapy group (P<0.001). The Kaplan-Meier event rate for the primary end point at 7 years was 32.7% in the simvastatin-ezetimibe group, as compared with 34.7% in the simvastatin-monotherapy group (absolute risk difference, 2.0 percentage points; hazard ratio, 0.936; 95% confidence interval, 0.89 to 0.99; P = 0.016). Rates of pre-specified muscle, gallbladder, and hepatic adverse effects and cancer were similar in the two groups. CONCLUSIONS: When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to levels below previous targets provided additional benefit